Kamran A. Ahmed, MD, discusses the need for multidisciplinary care in patients with HER2-positive breast cancer and leptomeningeal disease.
Kamran A. Ahmed, MD
Advertisement
Articles by Kamran A. Ahmed, MD
Kamran A. Ahmed, MD, discusses the impact of neratinib on patients with central nervous system metastases and HER2-positive breast cancer.
Kamran A. Ahmed, MD, discusses the role of multidisciplinary care in breast cancer–related brain metastases.
Kamran A. Ahmed, MD, discusses remaining questions with the use of tucatinib in breast cancer–related brain metastases.
Kamran A. Ahmed, MD, discusses key strategies to manage patients with breast cancer and brain metastases.
Advertisement
Latest Updated Articles
Dr. Ahmed on the Impact of Neratinib on CNS Metastases in HER2+ Breast CancerPublished: September 3rd 2020 | Updated:
Dr. Ahmed on Remaining Questions With Tucatinib in Breast Cancer Brain MetastasesPublished: August 6th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
5